El-Lab Limited

Medical Diagnostic & Research Centre

Phone: 08095461685, 08038229492, 08080733112
Email:info@el-lab.org, ellabfestac@gmail.com | www.el-lab.org
Welcome to El-Lab Limited

Dear Valued Customer:

Thank you for selecting El-Lab Limited as a provider for your preclinical and clinical
studies. Our Medical and Research facility is equipped with state of-the-art equipment
and facilities matching world class standards that offers a variety of standard and
specialized research services. We provide high-quality service and our staff strives to
exceed your expectations.

The Centre is fully registered with Corporate Affairs Commission and the Medical
Laboratory Science Council of Nigeria; accredited by NHIS and Lagos State Health
Facility Monitoring and Accreditation Agency (HEFAMAA) as a secondary healthcare
provider.

The laboratory's qualified scientists are available to respond to your technical needs.

This handbook is a team effort put together to provide information and a guide to our
laboratory users. The handbook will be reviewed from time to time in the future. In case
of suggestions or corrections on how to improve the clinical usefulness of the
handbook or other aspects of our services, please contact us through the following
telephone numbers or email addresses

Telephone: 08038229492, 08095461695, 08080733112

Email: info@el-lab.org I ellabfestac@gmail.com

Thank you for your business. We look forward to working with you.

Sincerely,

El-Lab Limited

El-Lab Limited
Medical Diagnostic & Research Centre
Phone: 08095461685, 08038229492, 08080733112
Email:info@el-lab.org, ellabfestac@gmail.com | www.el-lab.org
Table of Contents

Medical Diagnostic & Research Centre

Mission statement, vision, our core values ................................................... 3

Hours of Operation, Test Requisition ............................................................ 4

Sample collection and labeling.......................................................................... 4

Order for Draw Blood ..................................................................................... 5

Dispatch Pickup, Sample Transportation ................................................... 6

Ambulance Service .................................................................................... 6

Turn Around Time ...................................................................................... 7

Safety and universal precaution ............................................................... 12

Test results, QMS, Complaints and feedback .......................................... 12

Important information for clients ............................................................... 13

Agreement for Clinical Research Testing Service .................................... 15

Appendix 1 ............................................................................................... 20

Appendix 2 ............................................................................................... 21

Appendix 3 ............................................................................................... 22

Page 2 of 29
Medical Diagnostic & Research Centre

MISSION STATEMENT

To be a leading and trusted indigenous medical diagnostic institution in

the nation with acceptable international standard

OUR VISION

To be an indigenous standard and modern medical diagnostic institution

that makes steady scientific improvement in health care delivery
combining this with a culture of care and consistency.

CORE VALUES

• Godly Pathway
• Patient Care & Dignity
• Confidentiality
• Honesty
• Integrity
• Proficiency
• Consistency

Page 3 of 29
HOURS OF OPERATION
EL-Lab centre is opened from 8am-8pm, Mondays to Saturdays, 11am-5pm on
Sundays. 24 hours operation in view

TEST REQUISITION
The laboratory request form can be obtained from the reception desk. The
requesting Clinician/Client should endeavor to fill the required patient’s
information shown below

Sex and Age (A or Adult is unacceptable)

Name of Patient (Surname first)

Patients Phone number

Test Required

Nature of sample (Blood/Urine) etc

Relevant Clinical information/history

Name of Clinician requesting the test

Clinicians contact address and phone number

Date of test registration

SAMPLES COLLECTION AND LABELLING

The phlebotomist should ensure that the sample is collected in the right
container for the test required. All efforts must be made to avoid haemolysis.
Appropriate containers for samples have been indicated in table 1. The right
volume of blood to anticoagulant ratio should be collected as indicated on the
container by the manufacturer.
The date and time of sample collection must be indicated on the request form as
well as the sample container.
Information which must be labeled clearly with a printed barcode label on the
sample should include

Name of Patient

Age of patient

Date and time of specimen collection

Nature of Specimen (e.g Blood, Urine)
Take-home” specimen collection kits are available for the following tests:

Occult Blood

Sputum for Culture & Susceptibility

Stool for Culture & Susceptibility

Stool for Ova & Parasites

Urine for Culture & Susceptibility

When samples are collected at home in Take-home sample bottles, it must be

returned back to the centre as specified by the front desk officer for necessary
documentation to be done.
Page 4 of 29
 SAMPLE REJECTION CRITERIA
Purpose
In order to prevent the reporting of misleading results, it is important to have a
procedure for managing specimens that are unsuitable for analysis. In general
terms, a specimen must be rejected when the results obtained by analysis are
not a representation of the patient’s condition. Pre-analytical variables
contribute to the rejection of unsuitable specimens. These include but are not
limited to:
1. Mislabelling of tubes/specimens or inadequate identification/unlabelled
specimens
2. Identification on tubes/specimens does not correspond to details on request
form
3. Improper collection method (e.g. blood gas)
4. Improper ratio of sample to preservative/anti-coagulant
5. Broken or cracked tubes/specimens / Leaked in transit
6. Expired tubes used for sample collection
7. Incorrect transportation conditions (e.g. not shipped on ice, not wrapped in
foil)
8. Grossly haemolytic, lipaemic or icteric samples
9. Wrong preservative used (24 hour urines)
10. Wrong anti-coagulant/blood tube
 On occasion, at the discretion of the Medical Lab scientist/Pathology an
unsuitable sample may be run for good reason. The sample integrity
must be recorded with the result along with a warning for the results to
be treated with reserve.

Scope
This procedure provides instruction for:
1. Discarding a sample safely;
2. Arranging new specimens to be collected;
3. Management of incorrectly labelled samples;
4. Management of lipaemic samples;
5. Management of grossly haemolysed samples;
6. Management of icteric samples;
7. Management of samples collected incorrectly;
8. Management of a broken sample;
9. Management of samples received in expired tubes;
10. Management of samples collected by using incorrect collection technique;
11. Management of sample where details on form differ from details on the
specimen(s);
Page 5 of 29
12. Management of old/delayed samples;
13. Management of insufficient sample received for analysis.

Responsibility
1. All laboratory & technical staff or as designated by laboratory /
departmental management
2. All administrative and laboratory assistants involved and designated to
perform specimen reception duties
3. All administrative staff performing follow-up and resolution of unsuitable
specimens
4. All nursing and phlebotomy staff

Procedure
1. Discarding a sample safely & handling of a contaminated form
a) Wear appropriate PPE (gloves, safety glasses and laboratory coat)
when handling a leaked or broken sample.
b) Should the requisition form also be contaminated, place the requisition
form in a plastic sleeve and make a photo copy.
c) Contact a laboratory staff member to evaluate if the sample should be
discarded.
d) Discard broken/cracked or unsuitable samples into the appropriate
biohazardous sharps container.
e) Discard the contaminated requisition form into the biohazardous solid
waste container.
f) Make a note on the copied requisition form regarding the broken
specimen(s).

2. Arranging new samples

Very important: A doctor should never receive a report with “NOT DONE”
having not been notified of the problem, by the performing lab
a) Contact relevant doctor/ depot/ lab to arrange for a re-bleed.
b) Always result the current specimen with Not done. Provide an
explanation in the comment field as to why the sample is regarded as
unsuitable.
c) Re-do the new sample on a different lab number.
d) Ensure that collection conditions are repeated, e.g. fasting specimens.
e) An Incident report must be logged for every test that cannot be resulted
with the following information:
• Clear explanation of the problem
• Record of who was contacted to arrange a re-bleed

Page 6 of 29
3. Handling of incorrectly labelled samples
a) A re-bleed is not necessarily required for samples when the sample is
received unlabeled.
b) Record on the Requisition form “NO NAME ON TUBE”.
c) Should the name on the requisition form be different than the name on
the tube(s), do not process.
d) Arrange for a re-bleed.

4. Handling of Lipaemic, Haemolysed or Icteric samples

a) Lipaemic samples
The degree of lipaemia should be noted. Where gross lipaemia is
encountered, refer to a senior medical Lab Scientist or lab
director/Pathologist in order to ascertain the validity of results
obtained.
Add a comment to any released results indicating that all results
should be treated with reserve.
The assays which are invalid due to lipaemia must have a
comment in place of the result, stating that the result is invalid due
to lipaemia, e.g. “Regret, serum/plasma grossly lipaemic.
Unsuitable for Bilirubin assay”.

b) Haemolysed samples
Assays mostly affected by haemolysis are:
• Potassium
• LDH
• Inorganic phosphate
• Iron
• Magnesium.
Levels of all these are higher in red cells than in serum/plasma.
Results therefore become falsely raised when samples are
haemolysed.
Grossly haemolysed samples should not be analysed – request a new
sample.

c) Icteric samples
Tests affected by high Bilirubin levels (icteric) must be scrutinised
by a senior technologist in order to ascertain validity of results
obtained.
A comment must accompany any released results indicating that
all results should be treated with reserve.
Any results regarded as invalid must have a comment in place of
the result, stating that the result is invalid due to the sample being
icteric.

5. Incorrect tubes

Page 7 of 29
 a) If the sample was collected in the wrong container, check with the
relevant department whether the specimen is suitable for testing.
Certain tests can be done on alternative blood, e.g. Heparin plasma
can be used for specific chemistry or haematology tests.
b) If it is unsuitable, discard the tube(s) in the biohazardous waste bins for
Sharps waste.
c) Notify the collector or the doctor/Customer.
d) If necessary, arrange for a repeat sample
e) Assign a new lab number for the re-collected samples.

6. Broken / Cracked tubes

a) Wear PPE at all times.
b) Discard the broken specimen into the sharps biohazardous waste bin.
Use forceps where required.
c) Discard the sample safely and arrange for re-bleed.
d) Should a spillage occur whilst opening, clean the surface with undiluted
sodium hypochlorite (Jik) and absorbent paper.
e) Discard gloves in biohazardous waste bin.
f) If items to discard cannot fit into a sharps container- it can be placed in
a red bucket sealed and marked as requiring destruction.

7. Expired tubes
a) Expired tubes are not used past expiry dates
b) Discard the specimen(s).
c) Notify the collector and arrange with the patient for a re-bleed.
d) Assign a new lab number.
e) Document a comment onto the requisition regarding expired tubes.

8. Incorrect collection method

a) This also refers to unsuitable samples, e.g.
• Incorrect preservative added to urine collections
• Anti-coagulated sample where there is evidence of clot formation
• Specific collection instructions not adhered to e.g. diets (fasting),
protected from light (foil), shipped on ice or body temperature.
b) Call the patient for a re-bleed. Assign a new lab number.

9. Old/delayed samples
a) Depending on the test requested, professional judgment must be
applied as to whether a repeat sample is required or whether the test
can be performed.
b) Where relevant, enter the result(s) with a comment, stating to treat the
results with reserve and the reason.
Page 8 of 29
10. Insufficient samples
a) Request a new sample.

References:
Health and Safety manual.

Table 1 Order for Draw Blood

Page 9 of 29
Notes

• Do not use expired collection tubes.

• Do not use a frost-free freezer to store serum and plasma samples.
• Do not submit serum or plasma that has been thawed or thawed and re-
frozen.
• Do not freeze whole blood samples.
• Do not freeze urine samples.
• Haemolysed samples are not accepted
• Appropriate measures should be taken to avoid errors in sample
collection, barcode labeling and transportation
• Properly store your inventory of blood collection tubes.
• Label the side of containers/tubes (not the tops or lids).
– Required Info: Sample ID, Collection Date
– Type of sample (e.g., serum, plasma, urine, whole blood, etc.)

Page 10 of 29
 • Avoid obscuring samples when affixing the barcode labels to the
collectiontubes/containers.
• If an error is suspected, please discuss with the Medical Scientist as
soon as possible, otherwise the specimen maybe discarded and a
repeat requested.

Dispatch Pick-up Service

El-lab provides Dispatch service throughout Lagos State. For
Dispatch pickup, contact us via phone or email. For long-distance
clients, (e.g. FedEx or UPS) can be arranged.

Sample Transportation
Patient’s specimens coming from referral laboratories should be
brought soon after collection to the reception point in the laboratory for
proper documentation before they are distributed by the key
responsible staff to the respective units/benches where the requested
tests are performed.

Important packaging and pickup reminders:

Cautionary Note: Ensure that frozen specimens (plasma and serum)

remain frozen and are never allowed to thaw during packing and
transportation. Whole blood specimens are to be transported in
refrigerated conditions and are not to be frozen or come in direct contact
with ice during packing and transportation.

Ambulance Service
EL-Lab provides ambulance service to patients in Lagos and environs.

Tests Results
Patient’s results are reported in most cases according to standard International
Unit Format (SIU). The laboratory also has tests reference ranges for ease of
result interpretation. Unless when otherwise requested by our clients, test
results are picked up at the front desk. Concerted efforts are made to ensure
that tests are performed and results are ready for collection within the
turnaround time indicated in table 2. Alerts concerning delays due to equipment
breakdown or other unforeseen circumstances are communicated through
clients contact address, phone number or email. Also, panic values/grossly
abnormal test results are communicated to the clinician requesting the test
immediately.

Page 11 of 29
Table 2: Turnaround Times

S/N Test Type of Sample Turn Around

Time (TAT)
A. Serology/Immunology
1 Hepatitis B(sAg) Plasma/serum 45 mins
2 Hepatitis C (ab) Plasma/serum 45 mins
3 CD4 count Whole Blood 24 hours
4 CD4% Whole Blood 24 hours
5 Hepatitis B Profile Plasma/serum 1 hour
6 Hepatitis A (Hav) Plasma/serum 45 mins
7 Hepatitis B DNA Viral load Serum 10 days
8 Hepatitis B DNA Viral load “ 10 days
B. Molecular Biology
1 HIV Viral Load Plasma 10 days
2 HIV early infant Diagnosis Plasma
3 HBV DNA Viral Load Plasma
4 HIV Confirmatory Plasma/serum 1 week
C. Biochemical Analysis
1 LIPIDS 3 hours
i. Cholesterol Serum “
ii. HDL Serum “
iii. LDL Serum “
iv. Triglyceride Serum “
v. Homocysteine “ 4 days
2 LFT’s “
i. ALT(SGPT) Serum “
ii. AST (SGOT) Serum “
iii. Bilirubin Total Serum “
iv. Protein & Albumin Serum “
3 OTHERS
i. Glucose Tolerance Serum 4 hours
ii. Creatinine Serum 2 hours
iii. Urea Serum 3 hours
iv. Fasting Blood Sugar - Plasma 2 hours
Fbs
v. Random Blood Sugar Plasma “
- RBS
vi. 2hpp - Blood Sugar Plasma “
vii. Full Electrolytes Plasma/serum 1 hour
viii. Potassium Plasma/serum “
ix. Sodium Plasma/serum “

Page 12 of 29
 x. Chloride Plasma/serum “
xi. Bicarbonate Plasma/serum “
xii. Kidney Function Test Plasma/serum 3 hours
- (K.F.T.)
xiii. Prothrombin (INR) Whole Blood 4 hours
xiv. Glycocylated Whole Blood 2 hours
Heamoglobin -
Hba1c
xv. Hepatitis B Core Plasma/serum 3 hours
Antigen
xvi. Urea Plasma/serum “
xvii. Creatinine Plasma/serum 2 hours
xviii. Uric Acid Plasma/serum “
xix. Calcium Serum “
xx. Creatinine Clearance Urine/ 4 hours
Plasma/serum
xxi. Albumin Plasma/serum 2 hours
xxii. C.P.K. Plasma/serum 3 days
xxiii. Globulin Plasma/serum 3 hours
xxiv. Total Protein Plasma/serum 1 hour
xxv. Direct Bilirubin Plasma/serum 1 hour
xxvi. Alkaline Phosphatase Plasma/serum 3 hours
xxvii. Total Cholesterol Plasma/serum 2 hours
xxviii. C.S.F Sugar C.S.F 1 hour
xxix. C.S.F. Protein C.S.F 2 hours
xxx. Elect / Urea / Creat. Plasma/serum 3 hours
xxxi. Phosphate Plasma/serum 2 hours
xxxii. Magnesium Plasma/serum 24 hours
xxxiii. MICRO ALBUMIN (µ- Urine 2 hours
Albumin)
xxxiv. D-Dimer Plasma/serum 2 hours
xxxv. Total Protein * Plasma/serum 2 hours
xxxvi. C-Reactive Protein - Plasma/serum 2 hours
(CRP)
xxxvii. BHCG Plasma/serum 2 days
D. Haematology Analysis
1 Full Blood Count Whole Blood 1 hours
2. ESR Whole Blood 2 hours
3. MP Whole Blood 1 hour
4 Widal Whole Blood “
5 BPT Whole Blood 45 mins
6 Heamogoblin - (HB) Whole Blood 45 mins
7 Packed Cell Volume- (PCV) Whole Blood 45 mins
8 Total White Blood Count- Whole Blood 1 hour
(WBCT)
Page 13 of 29
9 Differential White Blood Cell - Whole Blood 1 hour
(WBCD)
10 Blood Film Morphology Whole Blood 5 hours
11 Blood group Whole Blood 2 hours
12 Genotype “ 1 hour
13 Retic Count “ 3 hours
14 Coombs Test Plasma 2 days
16 Ferritin Serum 2 days
17 Vitamin B12* “ 11 days
18 Bleeding Time Whole Blood 2 hours
19 Clotting Time “ “
20 Prothrombin Time/ Inr “ 4 hours
21 PTTK “ 2 days
22 Platelet Count “ 1 hour

E. Microbiology
1 Urinalysis Urine 2 hours
2. Occult Blood Stool “
3. Microfilaria Whole Blood 1 hours 30 mins
4 Gonorrhea Rapid Test * Swab “
5 Helicobacter Pylori (H. Pylori) Plasma/serum “
6 Chlamydia Test Swab “
7 Rheumatoid factor Plasma/serum “
8 Tuberculin Plasma/serum “
9 Mantoux Test Heaf test 3 days
10 Skin Snip For Microfilaria Skin scrap 3 hours
11 Skin Scraping For Fungi Skin scrap 1 day
Element
12 Blood Culture Whole blood 8 days
13 Sputum Zn For AFB X1, X2, Sputum 4 days
X3 (Each – 2,000)
14 Stool Microscopy R/E Stool 2 hours
16 Urine culture Urine 48 hours
17 Stool Culture Stool “
18 High vaginal swap (HVS) Swab “
19 Semen,, Exudates Semen “
20 Ear,Wound, Nose, Eye Swab “
21 Urethral, Swab “ “
22 Seminal Fluid Analysis Only Semen 4 hours
23 Sputum culture Sputum 48 hours
24 Seminal Fluid Analysis + M/C/S Semen “
25 Urinalysis + M/C/S Urine “
26 Fungi Culture “ 6 weeks
27 Stool M/C/S Stool 48 hours
Page 14 of 29
28 Syphillis Plasma/serum 1 hour
29 Sputum Zn For AFB X1 Sputum 2 days
30 Csf M/C/S & Chemistry c.s.f 48 hours
31 Tubex Plasma/serum 2 hours
32 Herpes Simplex “ 5 days
33 VDRL “ 45 mins
34 TPHA “ 15 days
F. Endocrine-Thyroid
1 Free T3 5 days
2. Free T4 “
3. Parathyroid Hormone “
4 Thyroid Antibodies “
G. Endocrine – Reproduction
1 B –Hcg* 2 hours
2. DHEA–S* 5 days
3. Fetal Hb* “
4 Growth Hormone “
5 B –Hcg* “
H. Infective
1 VARICELLA ZOSTER Igg 5 days
2. Aso Anti-Streptolysin 4 days
I. Tumor Marker
1 AFP (Alfa Feto Protein) Plasma/serum 3 days
2. Ca125 ( Ovary ) Plasma/serum 5 days
3. Ca-15-3 ( Breast) Plasma/serum “
4 Ca19-9 ( G.I.T,Pancreas ) Plasma/serum “
5 CEA (Git, Lung, Breast) Plasma/serum “
J. Auto – Immune
1 Antimullerian Hormone Plasma/serum 10 days
2. Ana Anti Nuclear Antibody Plasma/serum 5 days
3. Anf Anti-DNA (Antinuclear Plasma/serum 10 days
Factor)
K. Liver/Pancreas
1 Amylase 2 hours
2. GGT Plasma/serum 2 hours
3. G6 PD Plasma/serum 10 days
4 Lipase Plasma/serum 10 days
L. Diabetes
1 C-Peptide Plasma/serum 10 days
2. MICROALBUMIN ( Urine) Urine 2 hours
3. Insulin Fasting Plasma/serum “
4 Cortisol Plasma/serum 5 days
M. Cardiac/Muscle
1 Cardiac Markers Plasma/cell 2 hours
Page 15 of 29
2. CK Plasma/cell 2 hours
4 Myoglobin Serum Serum 2 hours
5 Troponin I Plasma/serum 2 hours
6 Troponin T Whole blood 24 hours
N. Histopathology
1 Histology - 7 days
2. CYTOLOGY (Aspirates, Body - 4 days
Fluids, Exudates)
3. Biopsy - “
4 Papsmear - “
5 Barr Body Study - “
6 FNAC ( Without Collection) - “
7 Gastric Washing, Pleural Fluid, - “
Sputum.
O. Drugs Of Abuse
1 Amphetamine (Urine) Urine 4 hours
2. Benzodiazepine (Urine) “ “
3. Morphine “ “
4 Opiates (Urine) “ “
5 Cocaine (Urine) “ “
6 Cannabis “ “
7 Barbiturates “ “
8 Ethanol “ “
9 Lead Blood 14 days
P. Immunoassay
1 FSH, LH, Prolactin, Plasma/serum 5 days
Progesterone (Each)
2. Eostrogen - E2 “ “
3. Thyroid Function Test (T3, T4, “ “
TSH)
4 Ovulation Profile “ “
5 Menstrual Disorder “ “
6 Male Fertility Test “ “
7 Female Fertility Test “ “
8 P.S.A. “ “
9 FSH-LH-Prolactin “ “
10 FSH-LH-Prolactin-Testosterone “ “
11 FSH-LH-Testosterone “ “
12 FSH-LH-Prolactin-TSH “ “

*TAT starts once blood has been drawn

Page 16 of 29
Quality Management System (QMS)
The laboratory employs a standard and comprehensive QMS to ensure that
reliable and reproducible results are reproduced to meet our client’s
expectation.

Quality Policy Statement

El-lab is a medical diagnostic facility with constant focus on gaining better
understanding of customers’ needs and expectations (achieved through
constant engagement, feedback and communication) and surpassing them with
the sole aim of always delivering cost effective quality services in the form of
accurate test results within predefined quick turnaround times.

Safety and universal precaution

Patients’ samples should be regarded as infectious and as such handled with
caution. Protective coverings such as laboratory coats and hand gloves must be
worn during collection and handling of patients samples. Sharp objects including
needles must be disposed in appropriate containers. Needles MUST NOT be
recapped. Waste must be segregated into infectious and non infectious. All
biological wastes should be well managed. In addition staff handling infectious
materials should be vaccinated against hepatitis B.

Complaints and feedback from clients/patients

Users of the laboratory are our treasured customers. They are most welcome to
send us feedback, criticisms and complaints about the services we render.
Client questionnaires and suggestion box are available at the front office desk.
Our customers should feel free to give us their feedback on our services. Also,
periodic customers’ surveys are conducted to evaluate our performance. We
count on your feedback to improve our service delivery. Please help us to serve
you better.

Pricing Information
Request a current price list by contacting the lab via e-mail at
info@el-lab.org, ellabfestac@gmail.com or by calling 08095461695.

Page 17 of 29
 IMPORTANT INFORMATION FOR ALL OUR CLIENTS
Kindly note that all rights are predicated on the fact that clients equally
accept all responsibilities.
THE RIGHTS OF CLIENTS THE RESPONSIBILITIES OF
CLIENTS

• Right to be served/treated with • To treat all El-Lab’s staff with

dignity and respect. dignity and respect.

• Right to expect that all • To follow El-Lab’s client

communications and records instructions/process diligently.
pertaining to their
case(s)/investigation(s) be treated
as confidential.

• Right to laboratory rules and • To take necessary preventive

regulations that apply to them as measures as advised to protect
clients and as to what facilities are themselves from infectious
available to them. disease.

• Right to seek second opinion • To be aware that El-Lab’s staff

about their investigations and/or will endeavor to always act in
diagnosis from another their best interests. However,
laboratory/diagnostic centre. being humans are amenable to
occasional mistakes and errors.

• Right to obtain details of their • To make full payment(s) for the

laboratory bill(s) services provided or contracted
promptly.

• Right to refuse to participate in • To respect the competence of the

human research studies health care team and support
personnel to make professional
decisions on client care.

Page 18 of 29
To Enable Us Serve You Better, Please Note the Following:

PAYMENT
• All services attract fees payable in full only at the designated payment
point.
• Kindly obtain receipts for all payments.

CONDUCT
• Please be orderly and wait to be called when it is your turn to be served.
• If you are delayed while our staff is attending to others, please bear with us.
• No inducements should be given to our staff in the conduct of their duties.
• This diagnostic centre has zero tolerance for intimidation/threats against
our staff who are helping to serve clients.
• We have a duty and responsibility to protect our staff/team from any form of
rude behavior from clients by reporting to appropriate authority for
necessary actions including prosecution.
• At all times, our staff are charged and committed to be polite and courteous
to all our esteemed clients and reciprocation of this gesture is expected.

N.B
• ALL ACTIVITIES IN THIS FACILITY ARE MONITORED AND
RECORDED BY CLOSE-CIRCUIT T.V (CCTV) ON A 24HOUR BASIS.

For enquiries or classifications, please request to speak with the Admin

Manager or call 08095461695, 08038229492

Page 19 of 29
EL-LAB REFUND POLICY
This policy is not intended to bring difficulties to patients; rather it’s based on
fairness and equity in order to help us serve you better based on our years of
professional experience.

Clients should please note:

• Any refund must be requested in writing

• Once samples have been collected, no refunds will be issued.
• We do not issue refund payments to third parties.
• A service charge of 20% will be deducted for payments done within a
period of 3 month for test not carried out.

• Refunds are processed beginning from the instant a refund request is

received; we will assess the eligibility of your claim within 10 working
days for formal administrative investigations.

• Refunds will not be made available for test not done for over a period
of 3 months and above, rather patients will be advised to run
investigations equal to the amount paid. This is also transferable.

Page 20 of 29
 Agreement for Clinical Research Testing Services
This agreement defines the terms under which El-lab Limited (“EL-LAB”),
through EL-LAB's Clinical Analysis Laboratory service, will provide
testingservices to you (“Client”).

Services

1. Submission of Samples. Client may request that EL-LAB perform

clinical research tests by sending a completed “EL-LAB-Patient Request
Form” to EL-LAB together with samples for analysis. EL-LAB will advise
Client if samples are in a damaged, contaminated or improperly
preserved condition or do not meet the sample volume requirements.
Upon acceptance, EL-LAB shall use its commercially reasonable efforts
to perform the requested test on schedule. EL-LAB shall assign
professionally qualified personnel to performthe test in conformance with
generally accepted professional standards and in compliance in all
material respects with all requirements of applicable laws and regulations.
At the conclusion of each test, EL-LAB will provide Client with a report
describing the results.

2. Delivery of Samples. Client shall transmit samples to EL-LAB in

appropriate packaging with markings clearly identifying the contents per
DOT regulations. If Client elects to use EL-LAB’s despatch service,
arrangements will be made to schedule the pickup.

3. Data, Reports and Sample Retention. Client may elect to have samples
and non-regulated data and reports returned, stored, or destroyed after
the test is complete. In the absence of a Client election, EL-LAB may
destroy all samples and non-regulated data and reports one week after
testing. Storage of samples and non-regulated data and reports is limited
to a maximum of twelve months. Return and storage fees are identified on
theprice list.

4. GLP. On request, EL-LAB will perform tests compliant with Good

Laboratory Practices for Non-Clinical Laboratory Studies (21 C.F.R. Part
58). CLIA-compliant testing is not available. Client shall confirm that EL-
LAB’stests will meet its needs before submitting any order.

5. Ownership. Client shall own the samples, reports, and any raw data
produced by a test. EL-LAB retains ownership of all testing methods and
advancements thereto created by EL-LAB. This agreement does not grant
any license or other rights to either party in any patent rights, know-how, or
other intellectual property rights of the other party.

Page 21 of 29
Compensation

6. Fees. Client shall pay EL-LAB the fee for each test that is listed on the
price list in effect at the time of testing. Fees for custom tests shall be paid
in advance. EL-LAB shall provide receipts (including applicable discounts
and credits) to Client for tests performed. Payment shall be due thirty days
after the date of the invoice. EL-LAB may refuse to accept furthersamples
or may withhold data and reports if invoices are not timely paid.Client shall
pay 1.5% interest on any amounts unpaid after thirty days orthe highest
rate allowed by law, whichever is less. For GLP studies that are inactive
for over six months, an additional storage fee will apply.

7. Repeats; Dilution. If it is necessary to repeat a test, e.g., when required

by the SOP due to particular machine outputs, Client shall pay for the
repeated test at a portion of the fee for the initial test.

Client Confidential Information

8. Non-Disclosure. EL-LAB shall exercise reasonable care to maintain in
confidence any confidential information disclosed by Client pursuant to
this agreement (“Confidential Information”) after disclosure, EL-LAB shall
only disclose the Confidential Information to its directors, officers,
employees, and agents as reasonably necessary to perform testing
services under this agreement.

9. Exceptions. The limitations on use and disclosure contained in this

agreement shall not apply to the extent that (a) EL-LAB is required to
disclosethe Confidential Information by law, provided that, EL-LAB shall
provide prompt written notice thereof to Client; or (b) the information was
(i) public knowledge at the time of disclosure by Client, or thereafter
became publicknowledge, other than as a result of acts attributable to EL-
LAB in violationhereof; (ii) rightfully known by EL-LAB prior to the date of
disclosure by Client;
(iii) disclosed to EL-LAB on an unrestricted basis from a third party not
under a duty of confidentiality to Client; or, (iv) independently developed by
employees or agents of EL-LAB without access to or use of the
ConfidentialInformation.

Disclaimer of Warranty; Limitation of Liability

10. No Warranty. EL-LAB does not represent or warrant that the testing in
whole or in part will be successful or achieve Client’s objectives.
TESTING, DATA, AND REPORTS ARE EACH PROVIDED “AS IS” AND
EL-LAB PROVIDES NO REPRESENTATIONS, WARRANTIES, OR
CONDITIONS OF ANY KIND, EXPRESS OR IMPLIED, AND DISCLAIMS
ANY IMPLIED WARRANTIES OF TITLE, ACCURACY,
COMPLETENESS, MERCHANTABILITY, FITNESS FOR A PARTICULAR
PURPOSE, OR NONINFRINGEMENT.

Page 22 of 29
11. Damages Limitation. UNDER NO CIRCUMSTANCES WILL EL-LAB
BE LIABLE TO CLIENT OR ANY THIRD PARTY FOR LOST
PROFITS,LOST OPPORTUNITIES, OR ANY INCIDENTAL, SPECIAL,
EXEMPLARY, OR CONSEQUENTIAL DAMAGES IRRESPECTIVE OF
THE THEORY UNDER WHICH SUCH ACTION IS BROUGHT,
WHETHER IT WAS CAUSED OR ALLEGEDLY CAUSED BY THE
NEGLIGENCE OF EL-LAB, OR WHETHER OR NOT EL-LAB HAS
BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES OR
LOSSES.

12. Liability Limitation. Independent of, severable from, and to be enforced

independently of any other provision of this agreement, UNDER NO
CIRCUMSTANCE SHALL EL-LAB’S AGGREGATE LIABILITY TO
CLIENT OR ANY THIRD PARTIES, UNDER ANY AND ALL PROVISIONS
OF THIS AGREEMENT, EXCEED THE TOTAL AMOUNT ACTUALLY
PAID BY CLIENT TO EL-LAB UNDER THIS AGREEMENT IN SIX
MONTHS PRIOR TO ANY CLAIM.

Indemnification

13. Indemnity. Client shall indemnify, defend and hold harmless EL-LAB,
its officers, directors, employees and agents from all losses, liabilities,
damages and expenses (including reasonable attorney’s fees and costs)
that they may suffer as a result of any claims, demands, actions or other
proceedings made or instituted by any third party against EL-LAB and
arising out of or relating to (a) any negligent, reckless or intentional acts or
omissions of Client, its employees, agents or representatives; (b) Client’s
use of any results of the testing; or, (c) Client’s failure to properly warn EL-
LAB of any dangerous property of any material Client provided to EL-LAB
under this agreement.

14. Procedure. EL-LAB shall promptly notify Client of any loss, liability,
damage or expense, or any claim, demand, action or other proceeding
with respect to which EL-LAB intends to claim such indemnification.
Client’s indemnity obligations under this article shall not apply to

15. amounts paid in any settlement if effected without the consent of

Client, which consent shall not be unreasonably withheld or delayed.
Client shall not settle or consent to an adverse judgment in any such
claim, demand, action or other proceeding that adversely affects the
rights or interests of EL-LAB or imposes additional obligations on EL-
LAB, without the prior express written consent of EL-LAB. EL-LAB, its
employees and agents shall cooperate fully with Client and its legal
representatives in the investigation of any action, claim or liability
covered by this indemnification.

Page 23 of 29
Miscellaneous

16. Disputes. The parties shall resolve disputes arising out of this
agreement, including disputes about the scope of this arbitration provision,
by final and binding arbitration seated and held in San Francisco, Nigeria
before a single arbitrator. JAMS shall administer the arbitration under its
comprehensive arbitration rules and procedures. The arbitrator shall award
the prevailing party its reasonable attorneys’ fees and expenses, and its
arbitration fees and associated costs. Any court of competent jurisdiction
may enter judgment on the award. Either party mayseek preliminary relief
from a court of competent jurisdiction to preventimminent or continuing
irreparable harm before filing a demand for arbitration.

17. Notices. Any consent, notice or report required or permitted to be given

or made under this agreement by one party to the other party shall
be in writing, delivered personally, by facsimile (and promptly confirmed by
personal delivery, U.S. first class mail, courier or nationally-recognized
delivery service), U.S. first class mail postage prepaid, courier or
nationally-recognized delivery service, and addressed to such address as
the addressee shall have last furnished in writing to the addressor. Such
consent, notice or report shall be effective upon receipt.

18. Entire Agreement. This agreement embodies the entire agreement

between the parties and supersedes any prior agreement respecting the
subject matter. This agreement may only be modified in writing signed by
authorized representatives of both parties. Any Client purchase orders
received by EL-LAB relating to services to be provided under this
agreement are solely for Client convenience, are not a part of this
agreement, and EL-LAB objects to any conflicting or additional terms
therein.

19. Force Majeure. Neither party shall be held liable or responsible to the
other party nor be deemed to have defaulted under or breached this
agreement for failure or delay in fulfilling or performing any obligation
under this agreement (other than an obligation for the payment of money
to EL-LAB) to the extent, and for so long as, such failure or delay is
caused byor results from causes beyond the reasonable control of the
affected party.
20. Export Restrictions. The rights and obligations of this agreement are
subject to the laws and regulations of the United States relating to the
export of products and technical information. Without limitation, each party
shall comply with all such applicable laws and regulations.

21. Assignment. Client shall not assign its rights or obligations under this
agreement, in whole or in part, by operation of law or otherwise, without
the prior express written consent of EL-LAB. Any purported assignment
in violation of this article shall be void.

Page 24 of 29
22. Use of Name. Except as required by law, Client shall not use the name
of EL-LAB or EL-LAB’s directors, officers, employees or representatives in
any advertising, news release or other publication, without prior express
written consent of EL-LAB.

23. Independent Contractor. The parties intend to create an independent

contractor relationship. Nothing herein shall be construed as creating a
partnership, a joint venture, an agency, or any other relationship.

24. No Third Party Beneficiaries. The testing is for the sole benefit of
Client. This agreement is not made for, and shall not benefit or create any
right or cause of action in favor of, any person or entity other than EL-LAB
and Client.

25. Headings. The headings used in this agreement are for reference only
and are not to be used in the interpretation of construction of this
agreement.

26. Governing Law. This agreement shall be governed by and construed

in accordance with Nigeria law, without regard to its conflicts of law
principles.

27. Waiver. Waiver or failure to enforce any provision of this agreement is

not a waiver of any future breach.

Page 25 of 29
Appendix 1
Doctors Referral/Request Page 1
RC:326391

Urgent Routine

Pre sent Medica tions if any LMP Fasting Non-Fasting

Day Mth Yr
S am ple Type: Venous B lood A rterial B lood Capillary B lood Urine CS F Others (Pase
le S pecify)

Provisional Diagnosis/Relevan t Clinical Details

CSF-Glucose CA15-3* B leeding Time

Glucose (Fasting) HBsAg Clotting Time
Bence Jones Protein (Urine)* HBsAg (Quantification)*
Glucose (Random) Faecal Occult Blood PT/INR
Electrolytes HBsAb
Glucose (2HPP) PTTK
Sodium HBcAb
OGTT Protein c*
Potassium HBeAg
Chloride HBA1c Protein S*
HIVI &II HBeAb
Bicarbonate C-Peptide* VWF*
Cd4 Count* HBcAb (IgM)
Calcium Insulin (Fasting)* Factors Assays*
HIVConfirmation (PCR)* HB Viral Load
Phosphate D-dimer
HIVGenotype* Anti-HCV
Magnesium Total Cholesterol HCV Genotype Fibrinogen
HIVViral load*
Creatinine HDL Cholesterol HC Viral Load* Coombs Test ( Direct)
HIVDrug Resistance Testing
Urea LDL Cholesterol Coombs Test (Indirect)
Antiphosphospholipid Antibody-IgG*
Uric Acid Triglycerides Ferritin*
Antiphosphospholipid Antibody-IgM*
Urinalysis VLDL Iron*
Rheumatoid Factor FoodScreen/Allergen
Creatinine Clearance LDL:HDL Ratio Inhalents Iron Binding Capacity (TIBC)*
ASO(Qualitative)
TC:HDL Ratio Transferin*
ASO(Quantitative)* Iron Studies (Serum Iron, TIBC, Transferin Saturation)*
Bilirubin (total) Widal
Marijuana (THC) Folic Acid*
Bilirubin (conj) Pregnancy Test (Blood)
AST (SGOT) TSH Cannabis Vitamin B12*
T4 ( Total) RPR/VDRL Anti D(RR) Antibody)Titre*
ALT (SGPT) Amphetamine
T3 (Total) TPHA*
GGT* Methamphetamine Vitamin D3*
T4 (Free) Chlamydia Cocaine
ALP H.Pylori (Blood)
T3 (Free) Opiates
ACP PTH* H.Pylori (Stool) Benzodiazepines Semen Analysis(& Culture)
LDH* Fertility Profile Herpes Simplex (HSV) I ;IgG, IgM*
Amylase Malaria Parasite
ß-HCG Herpes Simplex (HSV) II; IgG, IgM*
Pap Smear Malaria PCR
Prolactin Rubella-IgG* Barr Bodies
Total Protein Trypanosomes
FSH Rubella-IgM* Fluid Cytology
Albumin Microfilaria (Blood)
LH Cytomegalovirus (CMV)* FNAC
Globulin Histology small part Microfilaria (Skin Snip)
H o mo cyste in e* Estradiol (E2) HPVConfirmation (PCR)
Progesterone (Day 21) HPVGenotype
Histology large part Tuberculin
C K-M B* M. tuberculosis PCR
M yog lo bin* Progesterone HPVPCR
DHEA* FBC AFB
Trop o nin I* Toxoplasma-IgG*
DHEA-S* Hb/PCV Mantoux
Trop o nin T* Toxoplasma-IgM*
Testosterone WBC + Diff Count All Cultures & (Sensitivity)
CRP TORCH-IgG*
Reticulocyte Count* -Urine, Blood, HVS, Semen, Stool,
h sC R P Cortisol* TORCH-IgM* Exudate, Urethral, Sputum, Ear,
Anti-Mullerian Hormone (AMH) Mumps-IgG* ESR
G6 PD Qua n tita tive * Blood Film Nose, Throat Swab, Aspirate, Wound swap,
G6 PD Qua lita tive* Mumps-IgM* CSF, Catheter tip, Tissue, Endocervical
Paternity/Maternity Testing* Blood Group
M icro a lbu m in PSA (Total) Genotype Fungal Studies
S erum Osm o lality* PSA (Free) DNAProfile* Faecal Occult Blood
Bcr Abl Detection PCR* Hb Genotype (PCR)*
U rine Osm ola lity* AFP Hb DNAGenotype (Sequencing)* DNA Paternity Testing*
C SF-An a lysis CEA* Bcr Abl Quantitation TB Quantiferon*
Sickle Cell Disease PCR
C SF-Protein Ca125*
OTHERS (Please Specify)

Page 26 of 29
Appendix 2
Doctors Referral/Request Page2

Page 27 of 29
Appendix 3 BLOOD COLLECTION FLOWCHART

Order for collection received

by the Laboratory

Sample collection, documented

on the system and generated

Blood sample collected

in the phlebotomy

No Is sample
viable?

Yes No

Sample is transported Sample is rejected and

to the main another sample is
Laboratory requested

Laboratory
sample
receiving
process
begins

Prepared by Joy I Asuquo

Review Date: 15 September, 2015
Reviewed by Dr Ndubuisi Nwosu
th
Next Review Date: 14 September 2016
Approved by Prince Elochukwu Adibo
EL-PH.03 Ver 03

Page 28 of 29